Mortality data is a critical component of aggregated RWD when trying to identify vulnerable populations for early intervention, measure long term outcomes in clinical trials, or create survival curves for oncology studies. Any time new data is appended to deidentified RWD, it is important to consider the privacy implications and protection of that deidentified status: we discuss how to navigate these challenges with Shubh Sinha and the team at Integral in this new article: Navigating the Challenges of Utilizing Mortality Data
Read the full article to learn about how adding mortality data to your deidentified data lake, while preserving patient privacy, is effortless when working with Veritas Data Research and Integral.
Related Articles
View all
Veritas and Aidentified: Powering Wealth Intelligence with Mortality Data
Veritas Data Research and Truveta: Advancing Clinical Insights with Real-World Mortality Data
Veritas Data Research Partners with Northwestern University to Advance Cirrhosis Research
Request More Information
Speak to a Veritas expert to learn how subscribing to our data can make your organization’s operations and analytics more effective.
Contact us